Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2014 ACR/ARHP Annual Meeting: Alive and Growing

Susan Bernstein  |  Issue: February 2015  |  February 1, 2015

—David T. Felson, MD, MPH

Signaling Mutations

Wnt signaling pathways, which regulate cell development and play a role in the development of many organs and tissues, may offer more clues in who is at high risk for OA, said Rik Lories, MD, PhD, at KU Leuven in Belgium.

“Wnt is an appealing but mysterious cascade,” said Dr. Lories. He described a fly with Wnt signaling pathway mutation that was wingless and could not fly. “This truly is a substance that can create major events.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because Wnt is extremely unlikely to travel across more than one or two cells, Wnt-related proteins have very local effects on bone and cartilage, said Dr. Lories. His research on FRZB, a protein that plays a role in skeletal morphogenesis, sparked his interest in the Wnt pathway and its potential role in bone and joint diseases. FRZB may bind and inhibit Wnt. FRZB gene polymorphisms are associated with OA in humans, especially hip OA.

FRZB-knockout mice generated in his laboratory had more cartilage damage and loss of cortical bone density compared to healthy, wild-type mice, Dr. Lories said. Mice without another Wnt-binding protein, SFRP1, showed an increase of cortical bone. These findings point to the potential importance of this signaling pathway in OA pathogenesis, he said. Overexpression of FRZB and SFRP1 may overload the body’s system and have a direct effect on bone formation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Overactivation of beta-catenin, another molecule in the Wnt signaling cascade, is associated with OA as well, Dr. Lories said. “The surprising thing is that beta-catenin can be put into the center of cartilage. If you inhibit beta-catenin in articular chondrocytes, you also can get OA,” he said.

The Wnt signaling cascade may provide many clues to OA pathogenesis, but “this is not an easy therapeutic target,” Dr. Lories said.

Cells & Loading

Bone is constantly remodeled in the joints, coupled with bone resorption by osteoclasts and formation by osteoblasts, said Dr. Cao, a bone biologist studying the effects of bone marrow mesenchymal stem cells in OA progression.

“However, at the end of each cycle, bone remodeling will not change the architecture of bone,” said Dr. Cao. Calcium in the bone helps maintain constancy, he said.

Bone loading is an important factor in this cyclical process, illustrated by different animal families. Fish, for example, have no osteoclasts, no bone loading, and no bone remodeling. When amphibians first emerged from the sea onto dry land to walk, they developed osteoclasts. Dolphins, who may have returned to the sea from land, have no mechanical loading, but are intended to have solid bone like other mammals, so they show some bone remodeling and osteoclasts, he said.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)BernsteinboneOsteoarthritisResearch

Related Articles

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    A Passion for Multidisciplinary Collaboration

    February 3, 2012

    Through teamwork, David T. Felson, MD, MPH, has advanced understanding and treatment of rheumatic diseases

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

    New Treatments Needed to Prevent Fractures in Osteoporosis

    June 1, 2014

    Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences